Dose-response effects of pegylated human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet production end function in nonhuman primates.

被引：0
|
作者：
Harker, LA
Hunt, P
Marzec, UM
Kelly, AB
Tomer, A
Hanson, SR
Stead, RB
机构：
[1] EMORY UNIV,SCH MED,ATLANTA,GA
[2] AMGEN INC,THOUSAND OAKS,CA
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1012 / 1012
页数：1
相关论文
共 33 条
  • [1] Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates
    Harker, LA
    Marzec, UM
    Hunt, P
    Kelly, AB
    Tomer, A
    Cheung, E
    Hanson, SR
    Stead, RB
    BLOOD, 1996, 88 (02) : 511 - 521
  • [2] Effect of a single dose of pegylated human recombinant megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet counts: Implications for platelet apheresis.
    Tomita, D
    Petrarca, M
    Paine, T
    Olson, K
    Roskos, L
    Cheung, E
    Kisicki, J
    TRANSFUSION, 1997, 37 (09) : S8 - S8
  • [3] Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer
    Basser, RL
    Rasko, JEJ
    Clarke, K
    Cebon, J
    Green, MD
    Hussein, S
    Alt, C
    Menchaca, D
    Tomita, D
    Marty, J
    Fox, RM
    Begley, CG
    LANCET, 1996, 348 (9037): : 1279 - 1281
  • [4] Donors' willingness to participate in a trial of pegylated megakaryocyte growth and development factor (PEG-rHuMGDF) for plateletapheresis.
    McCullough, J
    Peterson, R
    Clay, M
    Pittelko, L
    Smith, J
    Edman, L
    Dragovich, S
    Herr, G
    Weiser, M
    BLOOD, 1997, 90 (10) : 3318 - 3318
  • [5] Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates
    Harker, LA
    Hunt, P
    Marzec, UM
    Kelly, AB
    Tomer, A
    Hanson, SR
    Stead, RB
    BLOOD, 1996, 87 (05) : 1833 - 1844
  • [6] The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation
    Schuster, MW
    Beveridge, R
    Frei-Lahr, D
    Abboud, CN
    Cruickshank, S
    Macri, M
    Menchaca, D
    Holden, J
    Waller, EK
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (09) : 1044 - 1050
  • [7] In vitro studies from a phase I randomized, blinded trial of pegylated megakaryocyte growth and development factor (PEG-rHuMGDF).
    Rasko, JEJ
    Basser, R
    OMalley, CJ
    Mansfield, R
    Boyd, J
    Grigg, A
    McGrath, K
    Marty, J
    Sheridan, W
    Hussein, S
    Berndt, MC
    Begley, CG
    BLOOD, 1995, 86 (10) : 1978 - 1978
  • [8] Single injection of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) promotes hematologic recovery in irradiated mice.
    Shibuya, K
    Takahashi, K
    Tahara, E
    Kato, T
    Akahori, H
    Miyazaki, H
    BLOOD, 1996, 88 (10) : 1400 - 1400
  • [9] Pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) increased platelet counts (PLT) in patients (pts) with aplastic anemia (AA) and myelodyplastic syndrome (MDS).
    Komatsu, N
    Okamoto, T
    Yoshida, T
    Nakao, S
    Urabe, A
    Nagasawa, T
    Yonemura, Y
    Takeshita, A
    Ikeda, Y
    Sawada, K
    Hotta, T
    Kanamaru, A
    Bessho, M
    Minami, N
    Okamura, T
    Jinnai, I
    Kanakura, Y
    Mizoguchi, H
    BLOOD, 2000, 96 (11) : 296A - 296A
  • [10] Effects of PEGylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) before high dose chemotherapy (HDC) with peripheral blood progenitor cell (PBPC) support.
    Glaspy, J
    Vredenburgh, J
    Demetri, GD
    Chap, L
    Gilbert, C
    Overmoyer, B
    Warren, DL
    Berg, R
    Scarlata, D
    Menchaca, D
    Bolwell, B
    BLOOD, 1997, 90 (10) : 2582 - 2582
1234